Case-controlled identification of colorectal cancer based on proteomic profiles and the potential for screening

Colorectal Disease

Volumn 16, Issue 11, 2014, Pages 907-913

  Huijbers, A ^a   Mesker, W E ^a   Mertens, B J ^a   Bladergroen, M R ^a   Deelder, A M ^a   van der Burgt, Y E M ^a   Tollenaar, R A E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal cancer; Early detection; MALDI TOF; Proteomics; Screening

Indexed keywords

TUMOR MARKER;

ADULT; AGED; BLOOD; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; EVALUATION STUDY; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROCEDURES; PROTEOMICS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84932124230     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12782     Document Type: Article

References (23)

1. Stoop EM, de Haan MC, de Wijkerslooth TR et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 2012; 13: 55-64.
2. Lieberman D. Progress and challenges in colorectal cancer screening and surveillance. Gastroenterology 2010; 138: 2115-26.
3. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
4. Davies RJ, Miller R, Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer 2005; 5: 199-209.
5. Miller S, Steele S. Novel molecular screening approaches in colorectal cancer. J Surg Oncol 2012; 105: 459-67.
6. Levi Z, Rozen P, Hazazi R et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007; 20: 244-55.
7. Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006; 107: 2152-9.
8. Johnson CD, Chen MH, Toledano AY et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008; 359: 1207-17.
9. Duffy MJ, van Dalen A, Haglund C et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 2007; 43: 1348-60.
10. Winawer S, Classen M, Lambert R et al. World Gastroenterology Organization/International Digestive Cancer Alliance Practice Guidelines for Colorectal Cancer Screening 2007.
11. Smith RA, Cokkinides V, Brooks D, Saslow D, Shah M, Brawley OW. Cancer screening in the United States, 2011: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2011; 61: 8-30.
12. Vogelstein B, Kinzler KW. Winning the war: science parkour. Sci Transl Med 2012; 4: 127ed2.
13. Hanash S. Disease proteomics. Nature 2003; 422: 226-32.
14. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
15. Huijbers A, Velstra B, Dekker TJ et al. Proteomic serum biomarkers and their potential application in cancer screening programs. Int J Mol Sci 2010; 11: 4175-93.
16. Bladergroen MR, Derks RJ, Nicolardi S et al. Standardized and automated solid-phase extraction procedures for high-throughput proteomics of body fluids. J Proteomics 2012; 77: 144-53.
17. Jimenez CR, El FZ, Knol JC et al. Automated serum peptide profiling using novel magnetic C18 beads off-line coupled to MALDI-TOF-MS. Proteomics Clin Appl 2007; 1: 598-604.
18. Callesen AK, Madsen JS, Vach W, Kruse TA, Mogensen O, Jensen ON. Serum protein profiling by solid phase extraction and mass spectrometry: a future diagnostics tool? Proteomics 2009; 9: 1428-41.
19. Velstra B, van der Burgt YE, Mertens BJ, Mesker WE, Deelder AM, Tollenaar RA. Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures. J Cancer Res Clin Oncol 2012; 138: 1983-92.
20. Taylor KL, Shelby R, Gelmann E, McGuire C. Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. J Natl Cancer Inst 2004; 96: 1083-94.
21. Zorzi M, Fedato C, Grazzini G et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut 2011; 60: 944-9.
22. Arora G, Mannalithara A, Singh G, Gerson LB, Triadafilopoulos G. Risk of perforation from a colonoscopy in adults: a large population-based study. Gastrointest Endosc 2009; 69(3 Pt 2): 654-64.
23. Ko CW, Riffle S, Michaels L et al. Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol 2010; 8: 166-73.